Lixte Biotechnology
LIXT
LIXT
11 hedge funds and large institutions have $1.24M invested in Lixte Biotechnology in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$62.6K | |
| 2 | +$16.5K | |
| 3 | +$4.16K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.03K |
Top Sellers
| 1 | -$8.11M | |
| 2 | -$50.7K | |
| 3 | -$40K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$32.2K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$7.36K |